METOPIMAZINE VENIPHARM 15 mg, gélule — plaquette(s) aluminium PVC PVDC de 20 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930305904
  • CIP7 3030590
  • CIS 64362325

What the source publishes

Holder
VENIPHARM
Active ingredients
MÉTOPIMAZINE
Form
gélule
Package
plaquette(s) aluminium PVC PVDC de 20 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
liste II
Marketing status
Déclaration de commercialisation
Authorised on
2024-11-19
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930305904
{
  "cis": "64362325",
  "cip7": "3030590",
  "form": "gélule",
  "name": "METOPIMAZINE VENIPHARM 15 mg, gélule — plaquette(s) aluminium PVC PVDC de 20 gélule(s)",
  "cip13": "3400930305904",
  "holder": "VENIPHARM",
  "routes": [
    "orale"
  ],
  "holders": [
    "VENIPHARM"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "3.79",
  "authorisedOn": "2024-11-19",
  "compositions": [
    {
      "name": "MÉTOPIMAZINE",
      "nature": "SA",
      "strength": "15,0 mg",
      "linkageNumber": "1",
      "substanceCode": "02376",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste II",
  "dispensingFee": "1.02",
  "medicinePrice": "2.77",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "METOPIMAZINE VENIPHARM 15 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) aluminium PVC PVDC de 20 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2026-06-16",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "MÉTOPIMAZINE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste II"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930305904"